Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05909904
Title	Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	BeiGene
Indications	pharynx squamous cell carcinoma laryngeal squamous cell carcinoma oral squamous cell carcinoma
Therapies	LBL-007 + Tislelizumab Tislelizumab BGB-A425 + Tislelizumab BGB-A425 + LBL-007 + Tislelizumab
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| ITA \| GBR \| FRA \| ESP \| CAN \| AUS